Suduvax / GC Biopharma - LARVOL DELTA

Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination (clinicaltrials.gov) - P2 | N=230 | Recruiting | Sponsor: Green Cross Corporation | N=501 ➔ 230

Enrollment change • Varicella Zoster

Evaluate the Safety and Immunogenicity After MG1111 as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st SUDUVAX Inj. Vaccination (clinicaltrials.gov) - P2 | N=501 | Recruiting | Sponsor: Green Cross Corporation | Not yet recruiting ➔ Recruiting

Enrollment open • Varicella Zoster